TrakCel is a United Kingdom based startup that specializes in transforming cellular orchestration for cell and gene therapy. The company's flagship platform, OCELLOS, manages and tracks all components of the cell and gene therapy supply chain, ensuring safe and efficient delivery of therapies to patients at both clinical and commercial stages. Founded in 2012, TrakCel's solutions cover the entire advanced therapy patient journey, providing comprehensive chain of custody, chain of identity, and traceability. The recent corporate round investment in 03 March 2021 saw participation from LabCorp and Cencora. TrakCel's innovative approach and focus on uniting and transforming the future of therapy supply chains position it as a key player in the supply chain industry. The company's commitment to driving efficiency and safety in the delivery of advanced therapies makes it a compelling prospect for potential investors.
No recent news or press coverage available for TrakCel.